Jay Backstrom

Celgene Corporation

QC-verified· April 2026 PI on 2 trials

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality
Autosomal dominant Charcot-Marie-Tooth disease type 2

Clinical trials (2)

NCT00179621
NCT03124459

Verify independently

ClinicalTrials.gov PI search for Jay Backstrom

Other specialists for Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality

Peers ranked by clinical-trial PI role, publications, and verification quality.

Ulrich Germing, Prof.
Heinrich-Heine University, Duesseldorf
Eric Feldman
Weill Medical College of Cornell University
Ghulam J Mufti, MB, DM, FRCP, FRCPath
King's College London
Rami Komrokji, M.D
H. Lee Moffitt Cancer Center and Research Institute
FL
Gail Brown
Telik
Sante Cundari
Celgene s.r.l.
Lars Möllgård
Nordic MDS Group
Lionel ADES
GFM

See all specialists for Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality →

← Back to specialists directory